MISSISSAUGA, Ontario, 09 oct. 2024 (GLOBE NEWSWIRE) -- Les médecins de famille de partout au Canada et des quatre coins du monde se donnent rendez-vous au Centre des congrès de Vancouver du 6 au 9 nov ...

– Data show that p300 KAT inhibitor KB-9558 was highly selective against human papillomavirus (HPV) oncoproteins E6 and E7, and therefore drove anti-tumor effects – ...

The event will discuss data from emerging OX40/OX40L inhibitors, including Inmagene’s IMG-007 - the only clinical-stage non-depleting anti-OX40 mAb. A live question and answer session will follow the ...

The innovative platform accompanies the launch of Qdata Retinitis Pigmentosa for life sciences and the development of Practice Insights for clinicians. SAN FRANCISCO, Oct. 09, 202 ...

MORRISVILLE, N.C., Oct. 09, 2024 (GLOBE NEWSWIRE) -- Syneos Health ®, a leading fully integrated biopharmaceutical solutions organization, today announced the appointment of Costa Panagos as CEO and a ...

OCALA, Fla., Oct. 09, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), announced today that Tom Equels, Chief Executive Officer of AIM, will participate in a ...

Gregory D. Gorgas, CEO of Artelo Biosciences, will be joining Jason McCarthy, Maxim’s Senior MD and Head of Biotechnology Research analyst, in a fireside chat on Wednesday, October 16, 2024 at 4:00 ...

We’re pleased to wrap up Q3 2024 and enter Q4 by announcing continued growth, and we’re honored that Encinitas Oral Surgery, Maxillofacial Surgery Center of Huntsville and Pickett Oral Surgery have ...

With locations in North America, Southeast Asia, and Europe, Booz Allen will assist the under-resourced health sector by amplifying the message of collaboration within a trusted community, including ...

SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, announces ...

About Entourage Health Corp. Entourage Health Corp. is the publicly traded parent Company of Entourage Brands Corp., a licence holder producing and distributing cannabis products for the medical and ...

About Avenue Therapeutics Avenue Therapeutics, Inc. (Nasdaq: ATXI) is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of neurologic ...